Kindstar Globalgene Technology, Inc. (KINDSTAR GLOBAL) disclosed a repurchase of 32,000 ordinary shares on 18 June 2026, equivalent to 0.0031 % of its outstanding share capital prior to the transaction. The shares, acquired on the Hong Kong Stock Exchange at prices ranging from HKD 0.95 to HKD 0.99 and a volume-weighted average of HKD 0.9558, were retained as treasury stock.

Following the transaction, Kindstar Global’s issued share count (excluding treasury shares) decreased to 1.03 billion, while treasury shares increased to 7.26 million, keeping total issued shares stable at 1.04 billion.

The latest buy-back forms part of the company’s mandate approved on 5 June 2026, which authorises the repurchase of up to 103.43 million shares. Cumulative repurchases under this mandate now stand at 199,500 shares, representing 0.0193 % of the share base on the mandate’s approval date. A 30-day moratorium on new share issues or treasury share disposals is in effect until 18 July 2026, in accordance with Hong Kong Stock Exchange rules.